Moderna’s Covid-19 Vaccine Is More Than 94% Effective, Preliminary Data Shows

Published 3 years ago
In this photo illustration the medical syringe is seen with

TOPLINE: Moderna’s Covid-19 vaccine is 94.5% effective in preventing the disease, preliminary data from large-scale phase three trials shows, the company announced in a press release on Monday.


The preliminary data is based on an evaluation of 95 confirmed Covid-19 infections among the trial’s 30,000 participants.

According to the company, 90 of the participants who got infected with Covid-19 are from the placebo group while only 5 cases of infection were seen in the group that received two doses of the vaccine.


This is a developing story. Check back for updates.

-By Siladitya Ray, Forbes Staff